Zhang L, Jensen R T, Maton P N
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
Am J Physiol. 1990 Sep;259(3 Pt 1):G436-42. doi: 10.1152/ajpgi.1990.259.3.G436.
To characterize the beta-adrenergic receptors on guinea pig gastric smooth muscle cells, we examined the effects of beta-adrenergic agonists and antagonists on biological activity, cellular adenosine 3',5'-cyclic monophosphate (cAMP), and radioligand binding. Adrenergic agonists, isoproterenol (ISO), epinephrine (EPI), and norepinephrine (NE), inhibited carbachol-stimulated contraction of muscle cells, with relative potencies (IC50S) of ISO (0.1 microM) greater than EPI (1.4 microM) greater than NE (11 microM). Each agonist increased cellular cAMP, with relative potencies (IC50S) of ISO (0.5 microM) greater than EPI (6.3 microM) greater than NE (56 microM). Binding of the nonselective beta-antagonist 125I-pindolol was temperature-dependent, saturable, reversible, and specific. 125I-pindolol binding was inhibited by the three agonists, with relative potencies (IC50S) of ISO (0.9 microM) greater than EPI (9.6 microM) greater than NE (112 microM). Pindolol inhibited binding of 125I-pindolol with an IC50 of 100 nM. The IC50 for inhibition of binding of 125I-pindolol by the relatively beta 2-selective antagonist ICI 118,551 was 70 nM and for the relatively beta 1-selective antagonist betaxolol was 1,000 nM. Computer analysis of the dose-inhibition curves for binding of 125I-pindolol for the antagonists indicated that gastric smooth muscle cells possess exclusively beta 2-adrenergic receptors of two classes, one class with a high affinity for ICI 118,551 (Kd = 50 nM) and the other with a low affinity for ICI 118,551 (Kd = 30 microM). Our results indicate that beta-adrenergic agonists interact with beta 2-adrenergic receptors on gastric smooth muscle cells to increase cellular cAMP and inhibit muscle contraction.
为了表征豚鼠胃平滑肌细胞上的β-肾上腺素能受体,我们研究了β-肾上腺素能激动剂和拮抗剂对生物活性、细胞腺苷3',5'-环磷酸(cAMP)和放射性配体结合的影响。肾上腺素能激动剂异丙肾上腺素(ISO)、肾上腺素(EPI)和去甲肾上腺素(NE)抑制了卡巴胆碱刺激的肌肉细胞收缩,其相对效力(IC50)为ISO(0.1 microM)大于EPI(1.4 microM)大于NE(11 microM)。每种激动剂均增加了细胞内cAMP,其相对效力(IC50)为ISO(0.5 microM)大于EPI(6.3 microM)大于NE(56 microM)。非选择性β-拮抗剂125I-吲哚洛尔的结合是温度依赖性的、可饱和的、可逆的且具有特异性。125I-吲哚洛尔的结合受到三种激动剂的抑制,其相对效力(IC50)为ISO(0.9 microM)大于EPI(9.6 microM)大于NE(112 microM)。吲哚洛尔以100 nM的IC50抑制125I-吲哚洛尔的结合。相对β2选择性拮抗剂ICI 118,551抑制125I-吲哚洛尔结合的IC50为70 nM,相对β1选择性拮抗剂倍他洛尔的IC50为1,000 nM。对拮抗剂与125I-吲哚洛尔结合的剂量抑制曲线进行计算机分析表明,胃平滑肌细胞仅具有两类β2-肾上腺素能受体,一类对ICI 118,551具有高亲和力(Kd = 50 nM),另一类对ICI 118,551具有低亲和力(Kd = 30 microM)。我们的结果表明,β-肾上腺素能激动剂与胃平滑肌细胞上的β2-肾上腺素能受体相互作用,以增加细胞内cAMP并抑制肌肉收缩。